Exhibit 107
Calculation of Filing Fee Tables
Form S-8
(Form Type)
IceCure Medical Ltd.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security Type | Security Class Title | Fee Calculation | Amount Registered(1) | Proposed Maximum Offering Price Per Share | Proposed Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | |||||||||||||||||||
Newly Registered Securities | ||||||||||||||||||||||||||
Fees to Be Paid | Equity | Ordinary shares, no par value | 457(c) 457(h) | 2,000,000 | (2) | $ | 0.6 | (4) | $ | 1,200,000 | $ | 0.00014760 | $ | 177.12 | ||||||||||||
Equity | Ordinary shares, no par value | 457(c) | 1,500,000 | (3) | 0.6 | (4) | 900,000 | $ | 0.00014760 | $ | 132.84 | |||||||||||||||
Total Offering Amounts | $ | 2,100,000 | $ | 309.96 | ||||||||||||||||||||||
Total Fees Previously Paid | ||||||||||||||||||||||||||
Total Fee Offsets | ||||||||||||||||||||||||||
Net Fee Due | $ | 309.96 |
(1) | Pursuant to Rule 416(a) under the Securities Act of 1933, as amended, or the Securities Act, this Registration Statement also covers an indeterminate number of additional securities which may be offered and issued to prevent dilution resulting from stock splits, stock dividends, recapitalizations or similar transactions. |
(2) | Represents Ordinary Shares reserved for issuance upon the exercise of options that may be granted under the IceCure Medical Ltd. 2024 Equity Incentive Plan, or the Plan, as amended from time to time. |
(3) | Consists of ordinary shares issuable upon vesting and settlement of Restricted Shares and Restricted Shares Units (RSUs) that are outstanding under the Plan. |
(4) | Estimated in accordance with Rule 457(c) and (h) under the Securities Act, based upon the average of the high and low sales prices of the Registrant’s ordinary shares as reported on the Nasdaq Capital Market on August 9, 2024. |